Netanyahu aims to phase out US military aid within 10 years, citing Israel’s growing capacity and the need for greater ...

Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission - including an outpatient dosing option using a single weight-based dose IND amendment ...

Ramp up of Phase 1 concentrator advancing to plan; first sale of concentrate completed Shaft #3 on track for April 2026; five ...

Enphase Energy started shipping its IQ9N-3P Commercial Microinverter across the United States in late December 2025. The ...

First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory markers ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for ...

Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced that it began production shipments of its IQ9N-3P™ Commercial Microinverter across the United States in late ...

GSK is shifting to specialty growth (HIV, oncology, asthma) with key launches and a deep late-stage pipeline—still ...

BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...

Nurix Therapeutics (NRIX) stock: bexobrutideg’s BTK degradation shows strong efficacy in B-cell cancers, backed by $650M cash ...

In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

Abstract: In high-power applications, such as wind power generation, dual three-phase permanent-magnet synchronous machines (PMSMs) with two power conversion channels grow in popularity owing to ...